These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2487613)

  • 1. Fifteen-year overview of the International Cell Exchange.
    Lau M; Terasaki P; Park MS; Barbetti A
    Clin Transpl; 1989; ():447-56. PubMed ID: 2487613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of HLA through an international cell exchange.
    Loon J; Terasaki PI; Takemura S; Park MS
    Clin Transpl; 1987; ():453-8. PubMed ID: 3154445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Cell Exchange: 1992.
    Lau M; Terasaki PI; Park MS
    Clin Transpl; 1992; ():457-73. PubMed ID: 1306719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Cell Exchange, 1994.
    Lau M; Terasaki PI; Park MS
    Clin Transpl; 1994; ():467-88. PubMed ID: 7547576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Cell Exchange, 1991.
    Lau M; Terasaki P; Park MS; Barbetti A
    Clin Transpl; 1991; ():385-400. PubMed ID: 1726463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1993 cell typings of the International Cell Exchange.
    Lau M; Terasaki PI; Park MS
    Clin Transpl; 1993; ():533-52. PubMed ID: 7918187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1990 cell typings in the International Cell Exchange.
    Lau M; Terasaki PI; Park MS; Barbetti A
    Clin Transpl; 1990; ():567-76. PubMed ID: 2103173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA typing of leukemic cells and lymphoblastoid cell lines: effects of non-HLA antibodies in common typing sera.
    DuBois D; Specian TL; Pollack MS
    Prog Clin Biol Res; 1977; 16():115-28. PubMed ID: 269454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.
    Doxiadis II; Witvliet M; Verduyn W; de Lange P; Tanke J; Schreuder GM; Persijn GG; Claas FH
    Clin Transpl; 2000; ():99-103. PubMed ID: 11512364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress report on the ASHI/CAP Histocompatibility Survey Program, 1981-1986.
    Duquesnoy RJ; Marrari M; Walker RH
    Arch Pathol Lab Med; 1987 Dec; 111(12):1101-5. PubMed ID: 3675146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the HLA proficiency testing for Central and East Europe.
    Bogunia-Kubik K; Lange A
    Int J Immunogenet; 2008 Aug; 35(4-5):409-16. PubMed ID: 18976448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interlaboratory variation in the detection of HPA-specific alloantibodies and in molecular HPA typing.
    Allen D; Ouwehand WH; de Haas M; Kekomaki R; Kaplan C; Metcalfe P
    Vox Sang; 2007 Nov; 93(4):316-24. PubMed ID: 18070276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
    Sasaki N; Idica A; Hall B; Terasaki PI
    Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International sera exchange analyses in relation to DNA sequences: summary report from 1990 to 1994.
    Park MS; Lau M; Geer LI; Terasaki PI
    Clin Transpl; 1994; ():489-508. PubMed ID: 7547578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-year study of HLA typing proficiency in Eurotransplant.
    Schreuder GM; Hendriks GF; D'Amaro J; Persijn GG
    Tissue Antigens; 1986 Mar; 27(3):131-41. PubMed ID: 3520950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.
    Tiercy JM; Stadelmann S; Chapuis B; Gratwohl A; Schanz U; Seger RA; Faveri GN; Kern M; Morell A; Schwabe R; Schneider P
    Bone Marrow Transplant; 2003 Sep; 32(6):623-7. PubMed ID: 12953136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.